- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
回落整理中且下跌趋势有所减缓。
- 长期趋势：
已有325家主力机构披露2025-06-30报告期持股数据，持仓量总计2.72亿股，占流通A股48.12%
- 波段诊断：
-
技术面诊股
诊断结果：6.8技术面打败了65%的股票
技术面评分前10的股票
近期的平均成本为23.29元。多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
平均成本
近期的平均成本为23.29元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"23.29","date":1761467845,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，接近行业平均水平。
[{"date":"2025.10.27","stock":"1.04","trade":"-0.12","ind":"1.18"},{"date":"2025.10.24","stock":"0.30","trade":"-0.63","ind":"0.71"},{"date":"2025.10.23","stock":"0.17","trade":"-0.36","ind":"0.22"},{"date":"2025.10.22","stock":"0.17","trade":"0.70","ind":"-0.07"},{"date":"2025.10.21","stock":"-0.48","trade":"0.86","ind":"1.36"},{"date":"2025.10.20","stock":"0.52","trade":"0.20","ind":"0.63"},{"date":"2025.10.17","stock":"-0.09","trade":"-0.94","ind":"-1.95"},{"date":"2025.10.16","stock":"0.66","trade":"0.75","ind":"0.10"},{"date":"2025.10.15","stock":"0.35","trade":"1.37","ind":"1.22"},{"date":"2025.10.14","stock":"0.44","trade":"0.32","ind":"-0.62"},{"date":"2025.10.13","stock":"-0.40","trade":"-0.86","ind":"-0.19"},{"date":"2025.10.10","stock":"2.16","trade":"1.31","ind":"-0.94"},{"date":"2025.10.09","stock":"1.37","trade":"0.26","ind":"1.32"},{"date":"2025.09.30","stock":"-0.50","trade":"0.12","ind":"0.52"},{"date":"2025.09.29","stock":"-0.72","trade":"0.13","ind":"0.90"},{"date":"2025.09.26","stock":"0.41","trade":"-0.51","ind":"-0.65"},{"date":"2025.09.25","stock":"-0.72","trade":"-0.70","ind":"-0.01"},{"date":"2025.09.24","stock":"0.72","trade":"1.12","ind":"0.83"},{"date":"2025.09.23","stock":"-0.32","trade":"-1.40","ind":"-0.18"},{"date":"2025.09.22","stock":"-0.58","trade":"-0.53","ind":"0.22"},{"date":"2025.09.19","stock":"0.00","trade":"-1.04","ind":"-0.30"}]
羚锐制药,上证指数,中药指数
压力支撑
该股压力位为23.18元，支撑位为22.91元。
[{"text":"\u538b\u529b\u4f4d","value":"23.18","date":1761494400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"22.91","date":1761494400,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.4资金面打败了55%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月28日 08:11
| 机构今日流向(万元) | -1357.07 | 机构5日流向(万元) | -3925.72 |
| 机构10日流向(万元) | -4011.42 | 机构20日流向(万元) | -10561.07 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少1726.61万股，其中基金数没有增加，主力净增仓2家，暂未发现中长期投资价值。
截止2025-06-30，共325家主力机构（基金320家，一般法人2家，社保基金2家，保险公司1家），持仓量总计27226.71万股，占流通A股48.12%
其中，基金持仓与2024-12-31相比：
增仓：74家 ，增持 1227.86万股
减仓：74家 ，减持 2794.12万股
新出现在主力名单中：153家 ，持有2461.73万股
从主力名单中消失：151家 ，原持有2875.16万股
其中，基金持仓与2024-12-31相比：
增仓：74家 ，增持 1227.86万股
减仓：74家 ，减持 2794.12万股
新出现在主力名单中：153家 ，持有2461.73万股
从主力名单中消失：151家 ，原持有2875.16万股
消息面诊股
诊断结果：5.9消息面打败了51%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 羚锐制药：10月24日获融资买入937.29万元
2025-10-25 - 行业周报|中药指数涨0.77%, 跑输上证指数2.
2025-10-24 - 羚锐制药：10月23日获融资买入910.14万元
2025-10-24 - 羚锐制药：10月22日获融资买入632.63万元
2025-10-23 - 羚锐制药：10月21日持仓该股ETF资金净流入45
2025-10-22 - 羚锐制药：10月21日获融资买入974.14万元
2025-10-22 - 羚锐制药：10月20日获融资买入1228.48万元
2025-10-21 - 券商观点|医药生物行业周报：中国药企ESMO大会表
2025-10-20 - 羚锐制药：10月17日持仓该股ETF资金净流入49
2025-10-20 - 羚锐制药：10月17日获融资买入1433.70万元
2025-10-18
消息列表
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-09-26 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-20 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-26 |
| 利好 | 分红转增 | 10派9.0元(含税) | 2025-04-26 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-04-26 |
| 一般消息 | 高管变动 | 因工作安排 | 2025-04-24 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-03-07 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-03-05 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-02-27 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-12-26 |
| 一般消息 | 重大事项 | 关联交易 | 2024-11-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.6行业面打败了83%的股票
中药行业最新资金流向
近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2025.10.27","price":"1.18","value":"-0.12"},{"date":"2025.10.24","price":"0.71","value":"-0.63"},{"date":"2025.10.23","price":"0.22","value":"-0.36"},{"date":"2025.10.22","price":"-0.07","value":"0.70"},{"date":"2025.10.21","price":"1.36","value":"0.86"},{"date":"2025.10.20","price":"0.63","value":"0.20"},{"date":"2025.10.17","price":"-1.95","value":"-0.94"},{"date":"2025.10.16","price":"0.10","value":"0.75"},{"date":"2025.10.15","price":"1.22","value":"1.37"},{"date":"2025.10.14","price":"-0.62","value":"0.32"},{"date":"2025.10.13","price":"-0.19","value":"-0.86"},{"date":"2025.10.10","price":"-0.94","value":"1.31"},{"date":"2025.10.09","price":"1.32","value":"0.26"},{"date":"2025.09.30","price":"0.52","value":"0.12"},{"date":"2025.09.29","price":"0.90","value":"0.13"},{"date":"2025.09.26","price":"-0.65","value":"-0.51"},{"date":"2025.09.25","price":"-0.01","value":"-0.70"},{"date":"2025.09.24","price":"0.83","value":"1.12"},{"date":"2025.09.23","price":"-0.18","value":"-1.40"},{"date":"2025.09.22","price":"0.22","value":"-0.53"},{"date":"2025.09.19","price":"-0.30","value":"-1.04"}]
上证指数,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 万邦德 | 33.92% | -1.24% | 6.0分 |
| 2 | 特一药业 | 25.52% | 16.38% | 6.2分 |
| 3 | 方盛制药 | 14.01% | -0.08% | 6.5分 |
| 4 | 吉林敖东 | 12.19% | 3.06% | 5.8分 |
| 5 | 信邦制药 | 9.14% | -0.26% | 5.6分 |
| 6 | 粤万年青 | 7.50% | 3.99% | 5.8分 |
| 8 | 金花股份 | 6.49% | -1.31% | 6.2分 |
| 10 | 陇神戎发 | 5.18% | 1.91% | 6.0分 |
| 12 | 羚锐制药 | 4.57% | 1.22% | 6.4分 |
| 14 | 佐力药业 | 4.42% | -0.49% | 5.1分 |
| 16 | 益盛药业 | 3.58% | 1.38% | 5.7分 |
| 18 | 华润三九 | 3.18% | 2.89% | 6.0分 |
| 20 | 桂林三金 | 2.87% | 1.01% | 5.9分 |
| 22 | 江中药业 | 1.66% | -0.51% | 5.5分 |
| 24 | 华森制药 | 1.55% | 1.31% | 5.9分 |
| 26 | 精华制药 | 1.37% | 1.64% | 5.8分 |
| 28 | 益佰制药 | 0.95% | 0.95% | 6.0分 |
| 30 | 上海凯宝 | 0.65% | 1.31% | 5.6分 |
| 32 | 红日药业 | 0.53% | 0.53% | 5.5分 |
| 34 | 汉森制药 | 0.46% | 0.15% | 5.6分 |
| 36 | 天士力 | 0.39% | -2.64% | 5.5分 |
| 38 | 东阿阿胶 | 0.13% | 0.55% | 5.4分 |
| 40 | 广誉远 | -0.77% | 1.32% | 5.9分 |
| 42 | 葵花药业 | -0.89% | 1.37% | 4.9分 |
| 44 | 中恒集团 | -1.06% | 0.00% | 5.4分 |
| 46 | 奇正藏药 | -1.24% | -0.49% | 5.9分 |
| 48 | 九芝堂 | -1.38% | 3.09% | 5.9分 |
| 50 | 康美药业 | -2.40% | 0.00% | 5.4分 |
| 52 | 仁和药业 | -2.51% | 0.81% | 5.6分 |
| 54 | 达仁堂 | -2.66% | -6.91% | 5.4分 |
| 56 | 康缘药业 | -2.92% | -3.30% | 5.3分 |
| 58 | 寿仙谷 | -2.95% | -1.16% | 5.6分 |
| 60 | *ST长药 | -3.28% | -0.52% | 3.9分 |
| 62 | 健民集团 | -5.07% | -1.21% | 5.0分 |
| 64 | 振东制药 | -5.98% | 1.02% | 5.0分 |
| 66 | - | -6.25% | 1.19% | 分 |
| 68 | ST香雪 | -8.15% | -6.56% | 3.8分 |
| 70 | 片仔癀 | -10.28% | -5.13% | 4.9分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 3/110 ， 2/110。
[{"date":"2025-06-30","value":"15.46","vol":"3.94"},{"date":"2025-03-31","value":"6.79","vol":"2.20"},{"date":"2024-12-31","value":"24.65","vol":"4.81"},{"date":"2024-09-30","value":"20.19","vol":"2.92"},{"date":"2024-06-30","value":"15.04","vol":"1.58"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
15.46 | 6.79 | 24.65 | 20.19 | 15.04 |
| 行业(%) | 3.94 | 2.20 | 4.81 | 2.92 | 1.58 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"81.33","vol":"52.43"},{"date":"2025-03-31","value":"76.77","vol":"52.92"},{"date":"2024-12-31","value":"75.82","vol":"52.40"},{"date":"2024-09-30","value":"75.00","vol":"52.75"},{"date":"2024-06-30","value":"76.04","vol":"53.12"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
81.33 | 76.77 | 75.82 | 75.00 | 76.04 |
| 行业(%) | 52.43 | 52.92 | 52.40 | 52.75 | 53.12 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 11/110 ， 21/110。
[{"date":"2025-06-30","value":"10.14","vol":"-6.98"},{"date":"2025-03-31","value":"12.29","vol":"-6.63"},{"date":"2024-12-31","value":"5.72","vol":"-6.97"},{"date":"2024-09-30","value":"10.07","vol":"-4.57"},{"date":"2024-06-30","value":"12.07","vol":"-4.39"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
10.14 | 12.29 | 5.72 | 10.07 | 12.07 |
| 行业(%) | -6.98 | -6.63 | -6.97 | -4.57 | -4.39 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"14.85","vol":"2.33"},{"date":"2025-03-31","value":"13.89","vol":"-36.42"},{"date":"2024-12-31","value":"27.19","vol":"-142.71"},{"date":"2024-09-30","value":"23.10","vol":"63.06"},{"date":"2024-06-30","value":"30.30","vol":"-13.80"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
14.85 | 13.89 | 27.19 | 23.10 | 30.30 |
| 行业(%) | 2.33 | -36.42 | -142.71 | 63.06 | -13.80 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 4/110 ， 38/110。
[{"date":"2025-06-30","value":"0.40","vol":"0.24"},{"date":"2025-03-31","value":"0.20","vol":"0.12"},{"date":"2024-12-31","value":"0.72","vol":"0.49"},{"date":"2024-09-30","value":"0.57","vol":"0.37"},{"date":"2024-06-30","value":"0.40","vol":"0.26"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.40 | 0.20 | 0.72 | 0.57 | 0.40 |
| 行业(次) | 0.24 | 0.12 | 0.49 | 0.37 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.93","vol":"1.17"},{"date":"2025-03-31","value":"0.58","vol":"0.60"},{"date":"2024-12-31","value":"1.88","vol":"2.40"},{"date":"2024-09-30","value":"1.55","vol":"1.79"},{"date":"2024-06-30","value":"1.01","vol":"1.23"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.93 | 0.58 | 1.88 | 1.55 | 1.01 |
| 行业(次) | 1.17 | 0.60 | 2.40 | 1.79 | 1.23 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 30/110 ， 33/110。
[{"date":"2025-06-30","value":"22.07","vol":"20.17"},{"date":"2025-03-31","value":"11.52","vol":"0.38"},{"date":"2024-12-31","value":"70.89","vol":"15.45"},{"date":"2024-09-30","value":"6.97","vol":"6.15"},{"date":"2024-06-30","value":"24.64","vol":"11.77"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 22.07 | 11.52 | 70.89 | 6.97 | 24.64 |
| 行业 | 20.17 | 0.38 | 15.45 | 6.15 | 11.77 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.68","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.51","vol":"1.46"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.44","vol":"1.40"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.68 | - | 1.51 | - | 0.44 |
| 行业 | 1.02 | 0.00 | 1.46 | 0.00 | 1.40 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 36/110 ， 24/110。
[{"date":"2025-06-30","value":"0.98","vol":"2.88"},{"date":"2025-03-31","value":"1.01","vol":"2.97"},{"date":"2024-12-31","value":"1.31","vol":"2.86"},{"date":"2024-09-30","value":"1.18","vol":"3.22"},{"date":"2024-06-30","value":"1.08","vol":"2.95"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
0.98 | 1.01 | 1.31 | 1.18 | 1.08 |
| 行业 | 2.88 | 2.97 | 2.86 | 3.22 | 2.95 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.58","vol":"2.11"},{"date":"2025-03-31","value":"0.65","vol":"2.20"},{"date":"2024-12-31","value":"0.92","vol":"2.09"},{"date":"2024-09-30","value":"0.84","vol":"2.40"},{"date":"2024-06-30","value":"0.77","vol":"2.22"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.58 | 0.65 | 0.92 | 0.84 | 0.77 |
| 行业 | 2.11 | 2.20 | 2.09 | 2.40 | 2.22 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 10/110 ， 17/110。
[{"date":"2025-06-30","value":"44.36","vol":"33.91"},{"date":"2025-03-31","value":"38.20","vol":"33.34"},{"date":"2024-12-31","value":"38.60","vol":"34.08"},{"date":"2024-09-30","value":"40.61","vol":"32.93"},{"date":"2024-06-30","value":"42.49","vol":"33.75"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
44.36 | 38.20 | 38.60 | 40.61 | 42.49 |
| 行业(%) | 33.91 | 33.34 | 34.08 | 32.93 | 33.75 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.81","vol":"0.74"},{"date":"2025-03-31","value":"0.62","vol":"0.72"},{"date":"2024-12-31","value":"0.63","vol":"0.74"},{"date":"2024-09-30","value":"0.69","vol":"3.16"},{"date":"2024-06-30","value":"0.74","vol":"1.63"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.81 | 0.62 | 0.63 | 0.69 | 0.74 |
| 行业(%) | 0.74 | 0.72 | 0.74 | 3.16 | 1.63 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信建投证券 | 2025-09-05 | 买入 | |
| 浙商证券 | 2025-08-25 | 买入 | |
| 东海证券 | 2025-08-22 | 买入 | |
| 开源证券 | 2025-08-20 | 买入 | |
| 长城证券 | 2025-08-20 | 增持 | |
| 国金证券 | 2025-08-19 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"3.62","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"4.65","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"5.68","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"7.23","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"8.34","blueLineValue":"1.47","type":"YC"}]